Biological Information

Background Information:

Bombesin receptors belong to the superfamily of G protein-coupled seven transmembrane proteins. G-protein-coupled receptors constitute one of the major signal transduction systems in eukaryotic cells. Coding sequences for these receptors, in those regions believed to contribute to the agonist-antagonist binding site, are strongly conserved across mammalian species. Bombesin receptors are widely distributed in the central nervous system and peripheral tissues. Bombesin BB2 (gastrin-releasing peptide, GRP) receptor agonism may promote gastric emptying, gastrointestinal transit, insulin secretion, inflammation, cell proliferation and tumors. Receptor antagonism may lead to abnormal social behavior.

Family:

GPCR

Sub Family:

Bombesin

Class:

Class A

Protein Name:

BB2

Uniprot Number:

P30550

Protein Aliases:

bombesin receptor 2

Gene Name:

GRPR

Gene ID:

2925

Gene Aliases:

BB2|BB2R

Accession Number:

NM_005314

Organism:

Human

Construct Details:

Full Length, Recombinant

Assay Information

Assay Type:

Biochemical

Assay Sub Type:

Binding

Detection Method:

Radiometry

Measured Response:

Scintillation

Testing Information

Procedure Summary:

Human recombinant bombesin BB2 receptors expressed in human HEK-293 cells are used in modified HEPES-KOH buffer pH 7.4. A 0.1 μg‡ aliquot is incubated with 0.05 nM [¹²⁵I] (Tyr⁴)-Bombesin for 60 minutes at 25°C. Non-specific binding is estimated in the presence of 1 μM GRP (human). Membranes are filtered and washed, the filters are then counted to determine [¹²⁵I] (Tyr⁴)-Bombesin specifically bound. Compounds are screened at 10 μM.
Note: ‡Membrane protein may change from lot to lot, the concentration used will be adjusted if necessary.

Ligand:

[¹²⁵I] (Tyr⁴)-Bombesin

Ligand Kd (nM):

0.062

Ligand Concentration:

0.05 nM

Non Specific:

1 µM GRP (human)

Incubation:

60 min at 25°C

Control Inhibitor:

GRP (human)

Criteria For Significance:

≥ 50% of max stimulation or inhibition

Test Concentration / Dose:

Suggested concentration for initial testing is 10 uM

Test Sample Requirements:

Minimum for 1) Screen: 25 μl of 10 mM stock -OR- 1 mg (pre-weighed). 2) Dose Response: 60 μl of 10 mM stock -OR- 1 mg (pre-weighed).

Minimum Order Quantity:

2

Turnaround Time

Standard:

15 Business Days

Reference Compound Data

PubChem ID

5486808

Name

Litorin

Measurement

0.0024μM - IC50

PubChem ID

16130995

Name

bombesin

Measurement

0.00022μM - IC50

PubChem ID

22146595

Name

Ranatensin

Measurement

0.0023μM - IC50

PubChem ID

6324606

Name

Neuromedin B

Measurement

0.079μM - IC50

PubChem ID

71312125

Name

(Tyr4)-Bombesin

Measurement

0.00016μM - IC50

PubChem ID

122130556

Name

GRP (human)

Measurement

0.000027μM - IC50

PubChem ID

Name

(D-Phe6,beta-Ala11,Phe13,Nle14)-Bombesin (6-14)

Measurement

0.00018μM - IC50

PubChem ID

Name

GRP (18-27)

Measurement

0.00022μM - IC50

Clinical Relevance

Therapeutic Area:

CNS/Addiction/Pain

Additional Information

Brand:

LeadHunter

Testing Location:

Taiwan - Taipei

RELATED SOLUTIONS

Item: PP16